Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
56.07
+0.90 (1.63%)
At close: Nov 20, 2024, 4:00 PM
67.51
+11.44 (20.40%)
Pre-market: Nov 21, 2024, 7:31 AM EST
Crinetics Pharmaceuticals Employees
Crinetics Pharmaceuticals had 290 employees as of December 31, 2023. The number of employees increased by 80 or 38.10% compared to the previous year.
Employees
290
Change (1Y)
80
Growth (1Y)
38.10%
Revenue / Employee
$3,583
Profits / Employee
-$958,310
Market Cap
5.20B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Select Medical Holdings | 54,600 |
Stevanato Group | 5,634 |
Waystar Holding | 1,400 |
Inspire Medical Systems | 1,011 |
Ionis Pharmaceuticals | 927 |
PROCEPT BioRobotics | 626 |
ADMA Biologics | 624 |
Avidity Biosciences | 253 |
CRNX News
- 6 days ago - UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting - GlobeNewsWire
- 8 days ago - Crinetics Pharmaceuticals, Inc. (CRNX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting - GlobeNewsWire
- 8 days ago - Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 9 days ago - Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock - GlobeNewsWire
- 6 weeks ago - Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock - GlobeNewsWire